• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛癌分析揭示 FH 作为肺腺癌潜在的预后和免疫生物标志物。

Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma.

机构信息

School of Public Health, Qingdao University, Qingdao, Shandong, China.

Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

出版信息

Dis Markers. 2021 Oct 26;2021:8554844. doi: 10.1155/2021/8554844. eCollection 2021.

DOI:10.1155/2021/8554844
PMID:34737838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8563123/
Abstract

Fumarate hydratase (FH) is an important enzymatic component in the tricarboxylic acid cycle. Studies have reported that FH plays an important role in hereditary leiomyomatosis and renal cell cancer (HLRCC). However, the role of FH in human different cancers remains unknown. This study is aimed at analyzing the prognostic value of FH and demonstrating the correlation between FH expression and tumor immunity. Results showed that FH was mutated or copy number varied in 27 types of cancer. FH mRNA was abnormally upregulated across various cancers. Survival analysis suggested high expression of FH was associated with poor prognosis in many cancer types, including lung adenocarcinoma (LUAD). Additionally, FH expression was associated with immune infiltration, including B cells, CD4 T cells, CD8 T cells, neutrophils, macrophages, and dendritic cells, especially in liver hepatocellular carcinoma (LIHC), LUAD, and lung squamous cell carcinoma (LUSC). Moreover, FH expression showed a strong correlation with immune checkpoint markers in LUAD and testicular germ cell tumors (TGCT). These results indicate that FH is an immunotherapeutic target and a potential prognostic biomarker in LUAD.

摘要

延胡索酸水合酶(FH)是三羧酸循环中的一个重要酶成分。研究表明,FH 在遗传性平滑肌瘤病和肾细胞癌(HLRCC)中发挥着重要作用。然而,FH 在人类不同癌症中的作用尚不清楚。本研究旨在分析 FH 的预后价值,并展示 FH 表达与肿瘤免疫之间的相关性。结果表明,FH 在 27 种癌症中发生了突变或拷贝数改变。FH mRNA 在各种癌症中异常上调。生存分析表明,FH 的高表达与多种癌症类型的不良预后相关,包括肺腺癌(LUAD)。此外,FH 表达与免疫浸润有关,包括 B 细胞、CD4 T 细胞、CD8 T 细胞、中性粒细胞、巨噬细胞和树突状细胞,尤其是在肝肝细胞癌(LIHC)、LUAD 和肺鳞状细胞癌(LUSC)中。此外,在 LUAD 和睾丸生殖细胞肿瘤(TGCT)中,FH 表达与免疫检查点标志物呈强相关性。这些结果表明,FH 是 LUAD 中的一种免疫治疗靶点和潜在的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/e2132af1c963/DM2021-8554844.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/2e3ead6fb974/DM2021-8554844.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/f186154a74db/DM2021-8554844.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/c3b000e59da4/DM2021-8554844.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/21d1c7e16691/DM2021-8554844.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/e2132af1c963/DM2021-8554844.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/2e3ead6fb974/DM2021-8554844.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/f186154a74db/DM2021-8554844.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/c3b000e59da4/DM2021-8554844.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/21d1c7e16691/DM2021-8554844.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3826/8563123/e2132af1c963/DM2021-8554844.005.jpg

相似文献

1
Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma.泛癌分析揭示 FH 作为肺腺癌潜在的预后和免疫生物标志物。
Dis Markers. 2021 Oct 26;2021:8554844. doi: 10.1155/2021/8554844. eCollection 2021.
2
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.SEC61G 在肺腺癌中的预后价值:基于生物信息学和体外验证的综合研究。
BMC Cancer. 2021 Nov 13;21(1):1216. doi: 10.1186/s12885-021-08957-4.
3
TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.TOX 与肺腺癌的预后、免疫浸润和 T 细胞耗竭相关。
Cancer Med. 2020 Sep;9(18):6694-6709. doi: 10.1002/cam4.3324. Epub 2020 Jul 23.
4
Unveiling ficolins: diagnostic and prognostic biomarkers linked to the Tumor Microenvironment in Lung Cancer.揭示纤维胶凝蛋白:与肺癌肿瘤微环境相关的诊断和预后生物标志物。
World J Surg Oncol. 2024 Oct 10;22(1):273. doi: 10.1186/s12957-024-03558-4.
5
System analysis of in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.肺腺癌(LUAD)和肺鳞癌(LUSC)中 的系统分析:表达、预后、基因调控网络和调控靶点。
Int J Biol Markers. 2022 Jun;37(2):158-169. doi: 10.1177/03936155221084056. Epub 2022 Mar 7.
6
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.泛癌症分析免疫细胞浸润鉴定出肺腺癌预后免疫细胞特征评分(ICCS)。
Front Immunol. 2020 Jun 30;11:1218. doi: 10.3389/fimmu.2020.01218. eCollection 2020.
7
Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.TTC21A 在肺腺癌中的高表达预示着良好的预后和高水平的免疫浸润。
Int Immunopharmacol. 2020 Jan;78:106077. doi: 10.1016/j.intimp.2019.106077. Epub 2019 Dec 5.
8
Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.泛癌分析 PARP1 改变作为预测免疫治疗效果的生物标志物及其表达水平与免疫治疗特征的关联。
Front Immunol. 2021 Aug 31;12:721030. doi: 10.3389/fimmu.2021.721030. eCollection 2021.
9
Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.肺腺癌中预后标志物 AHNAK2 与免疫浸润的相关性。
Int Immunopharmacol. 2021 Jan;90:107134. doi: 10.1016/j.intimp.2020.107134. Epub 2020 Nov 7.
10
ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.ERCC6L是非小细胞肺腺癌的一种生物标志物和治疗靶点。
Med Oncol. 2022 Feb 12;39(5):51. doi: 10.1007/s12032-022-01654-7.

引用本文的文献

1
Identification of a Difluorinated Alkoxy Sulfonyl Chloride as a Novel Antitumor Agent for Hepatocellular Carcinoma through Activating Fumarate Hydratase Activity.通过激活富马酸水合酶活性鉴定二氟烷氧基磺酰氯作为一种新型肝细胞癌抗肿瘤剂
Pharmaceuticals (Basel). 2023 Dec 8;16(12):1705. doi: 10.3390/ph16121705.
2
KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses.KIF11 作为一种潜在的泛癌免疫生物学标志物,涵盖疾病分期、预后、肿瘤微环境和治疗反应。
Oxid Med Cell Longev. 2022 Dec 16;2022:2764940. doi: 10.1155/2022/2764940. eCollection 2022.
3

本文引用的文献

1
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.胃癌中形成竞争性内源RNA网络的生存相关长链非编码RNA、微小RNA和信使RNA的综合分析
Front Genet. 2021 Mar 2;12:610501. doi: 10.3389/fgene.2021.610501. eCollection 2021.
2
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma.头颈部鳞状细胞癌的肿瘤微环境与免疫相关疗法
Mol Ther Oncolytics. 2021 Jan 21;20:342-351. doi: 10.1016/j.omto.2021.01.011. eCollection 2021 Mar 26.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma.
CDH 家族成员在肺腺癌中的表达谱及预后价值。
Dis Markers. 2022 Feb 11;2022:9644466. doi: 10.1155/2022/9644466. eCollection 2022.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Immunological Role and Prognostic Value of APBB1IP in Pan-Cancer Analysis.泛癌分析中APBB1IP的免疫作用及预后价值
J Cancer. 2021 Jan 1;12(2):595-610. doi: 10.7150/jca.50785. eCollection 2021.
5
Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role.线粒体自噬相关蛋白PINK1作为免疫和预后作用生物标志物的泛癌分析
Front Oncol. 2020 Nov 10;10:569887. doi: 10.3389/fonc.2020.569887. eCollection 2020.
6
BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.BRCA1相关蛋白是一种潜在的预后生物标志物,与肝细胞癌的免疫浸润相关:一项泛癌分析。
Front Mol Biosci. 2020 Nov 2;7:573619. doi: 10.3389/fmolb.2020.573619. eCollection 2020.
7
Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.泛癌症分析鉴定 ESM1 为食管癌的一种新型癌基因。
Esophagus. 2021 Apr;18(2):326-338. doi: 10.1007/s10388-020-00796-9. Epub 2020 Nov 11.
8
NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis.NFE2L2 是脑低级别胶质瘤的一个潜在预后生物标志物,与免疫浸润相关:泛癌症分析。
Oxid Med Cell Longev. 2020 Oct 9;2020:3580719. doi: 10.1155/2020/3580719. eCollection 2020.
9
DNA mismatch repair-dependent DNA damage responses and cancer.DNA 错配修复依赖性 DNA 损伤反应与癌症。
DNA Repair (Amst). 2020 Sep;93:102923. doi: 10.1016/j.dnarep.2020.102923.
10
Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.异常 PD-1 和 CTLA4 表达对癌症免疫和预后的临床意义:泛癌症研究。
Front Immunol. 2020 Sep 10;11:2048. doi: 10.3389/fimmu.2020.02048. eCollection 2020.